They’ve dominated the tax press. You’ve bookmarked the opinions. They’re sitting in that “read later” pile that somehow never gets smaller. Time to catch up—fast. Join our panel of seasoned tax litigators as they cut through the noise and discuss what really matters from cases like 3M, AbbVie, Facebook, and Medtronic; explore how Eaton is playing out in practice; explain what Jarkesy has to do with tax; and attempt to predict where the economic substance doctrine stands as we move into 2026.